Biosciences Company Lands $2M+ in Funding

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Scioto Biosciences Inc. has closed a $1.8 million round of funding and has also been awarded nearly $400,000 in grants from the National Institutes of Health and the state of Indiana. The preclinical stage company says it will use the funds to further the development of its microbiome platform technology.

Scioto Biosciences says its focus is on developing innovative therapies to transform the delivery of microbiome therapeutics. The funding round included investments from BioCrossroads, Elevate Ventures and Ohio-based Rev1 Ventures. The company also received a $330,000 Small Business Technology Transfer grant from the NIH and a $50,000 match from the state.

"We are delighted that a team of important investors has shown confidence in our microbiome platform technology and sees its commercialization potential," said Joe Trebley, chief executive officer of Scioto Biosciences. "Our strong IP portfolio, executive and scientific team and working relationships with organizations like the Research Institute of the Nationwide Children’s Hospital in Columbus, Ohio has put us in a strong position to meet clinical needs in multiple therapeutic markets."

Among the treatments Scioto is seeking to develop is one to combat necrotizing enterocolitis, which the company says is now the leading cause of death from gastrointestinal disease in premature infants. Gail Besner, co-founder of Scioto and chief of pediatric surgery at Nationwide Children's Hospital, says the company is working to develop a probiotics-based solution that could be groundbreaking for the preventative treatment of NEC.

"Working together with Scioto and studying the development of our microbiome platform, you can really see the potential for not only helping prevent NEC, but also tackling other disease states in both human and animal health," said Steve Goodman, co-founder of Scioto and associate professor of pediatrics at Nationwide Children’s Hospital. "This could change the delivery system of many developing microbiome treatments and help advance a rapidly-growing field."

Scioto Biosciences was founded in May of 2017 and is headquartered at the Indiana Center for Biomedical Innovation just north of downtown Indianapolis.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...

    • Rose-Hulman Adds New Major

      Rose-Hulman Institute of Technology students now have another option when choosing a major. The Institute has added a engineering design major which is expected to offer a multidisciplinary experience. Students are enrolled to start the new program in the 2018-2019 school year. 

    • GM recently announced it would invest more than $1 billion in its Fort Wayne Assembly plant.

      Auto Job Fair Coming to Allen County

      General Motors is hiring more than 100 new employees in Fort Wayne. The positions in everything from finance to manufacturing are following a gradually increasing presence in the area for the past few years. In 2016, the company invested $127 million in its casting plant in Bedford and planned to pump an additional $1 billion into the Fort Wayne area over the next few years to double the size of its operation. The expansion of GM’s operations has led to increased business for ...